Cargando…
The current understanding of the immune landscape relative to radiotherapy across tumor types
Radiotherapy is part of the standard of care treatment for a great majority of cancer patients. As a result of radiation, both tumor cells and the environment around them are affected directly by radiation, which mainly primes but also might limit the immune response. Multiple immune factors play a...
Autores principales: | Iliadi, Chrysanthi, Verset, Laurine, Bouchart, Christelle, Martinive, Philippe, Van Gestel, Dirk, Krayem, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060828/ https://www.ncbi.nlm.nih.gov/pubmed/37006319 http://dx.doi.org/10.3389/fimmu.2023.1148692 |
Ejemplares similares
-
Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research
por: Cogels, Morgane M., et al.
Publicado: (2021) -
Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?
por: Bouchart, Christelle, et al.
Publicado: (2020) -
Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy?
por: Benkhaled, Sofian, et al.
Publicado: (2023) -
Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2
por: Bouchart, Christelle, et al.
Publicado: (2019) -
Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation
por: Manderlier, Martin, et al.
Publicado: (2022)